Illinois Neurological Institute

Evaluations and Testing

Evaluations

Soon, all MS patients new to our center take part in a comprehensive MS exam. This may includes:

  • ARMS - The Assessing Relapse in Multiple Sclerosis (ARMS) questionnaire is a 2-part, 2-page survey, with each part comprising 7 questions. Part 1 is designed to evaluate the patient's relapse symptoms and how the symptoms affect daily activities and overall function, as well as patient's response to past treatments for previous relapses, as a means of guiding treatment selection. Part 2 is designed to evaluate treatment response in terms of symptom relief and functioning, as well as treatment tolerability
  • Cognitive Evaluation
  • EDSS - The Expanded Disability Status Scale (EDSS)  is one of the oldest and probably the most widely utilized assessment instrument in MS (Kurtzke, 1983). Based on a standard neurological examination, the 7 functional systems (plus "other") are rated. These ratings are then used in conjunction with observations and information concerning gait and use of assistive devices to rate the EDSS. Each of the Functional System Scores is an ordinal clinical rating scale ranging from 0 to 5 or 6. The EDSS is an ordinal clinical rating scale ranging from 0 (normal neurologic examination) to 10 (death due to MS) in half-point increments. The FSS and EDSS have been used in virtually every major clinical trial that has been conducted in MS during the last four decades and in numerous other clinical studies.
  • MFIS - The Modified Fatigue Impact Scale (MFIS) provides an assessment of the effects of fatigue in terms of physical, cognitive, and psychosocial functioning.
  • MSQOL-54 - Multiple Sclerosis Quality of Life (MSQOL-54) is a multidimensional health-related quality of life measure that combines both generic and MS-specific items into a single instrument. (Vickrey et al, 1995) (Vickrey et al, 1997) The developers utilized the SF-36 as the generic component to which 18 items were added to tap MS-specific issues such as fatigue, cognitive function, etc. This 54-item instrument generates 12 subscales along with two summary scores, and two additional single-item measures. The subscales are: physical function, role limitations-physical, role limitations-emotional, pain, emotional well-being, energy, health perceptions, social function, cognitive function, health distress, overall quality of life, and sexual function. The summary scores are the physical health composite summary and the mental health composite summary. The single item measures are satisfaction with sexual function and change in health.
  • PHQ 2/9 - Patient Health Questionnaire TPHQ-9 and PHQ-2) offer providers concise, self-administered tools for assessing depression. They incorporate depression criteria with other leading major depressive symptoms into a brief self-report instruments that are commonly used for screening and diagnosis, as well as selecting and monitoring treatment.
  • WPAI-6 - Work Productivity Activity Impairment (WPAI-6) respondents are asked questions about work and activity impairment due to multiple sclerosis.  

Testing

Tests are an important part of an MS diagnosis and may be needed to determine the effectiveness of your current  treatment plan. The following tests are performed at our center:

  • Bladder Ultrasound
  • Brainstem Auditory Evoked Potentials (BAEP) (onsite)
  • Lab Draws (onsite)
  • EKG (onsite)
  • Lumbar puncture
  • MRI (3.0 T)
  • Neuropsychology evaluations
  • OCT (onsite)
  • Sedation MRI
  • Somatosensory Evoked Potentials (SSEP)
  • Visual Evoked Potentials (VEP)